secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0000950170-25-053325
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos receives Nasdaq deficiency notice for equity below $2.5M minimum; 45 days to submit plan
--------------------------------------------------------------------------------

- Stockholders' equity of $2.063M as of Dec 31, 2024, falls short of Nasdaq's $2.5M minimum under Rule 5550(b)(1).
- Company has 45 days from Apr 7, 2025 to submit a compliance plan; if accepted, may have up to 180 days to cure.
- Nasdaq also removed the one-year Panel Monitor that had been in place since February 2024.
- The deficiency notice does not immediately affect listing, but non-compliance could lead to delisting.
- Company intends to evaluate options and submit a plan to regain compliance within the allowed timeframe.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025053325/0000950170-25-053325-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025053325/tcrt-20250407.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-053325

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer